ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies
September 19, 2023 07:03 ET
|
Axovia Therapeutics LTD
Developing the first gene therapy to treat diseases caused by cilia dysfunctionAXV101 targets retinal dystrophy for Bardet-Biedl Syndrome (BBS) patientsFDA Orphan Drug Designation and Rare Pediatric...